A Tuberculose dos Seropositivos é uma doença nova*

Evolving trends revealed by autopsies of patients with the acquire-dimmunodeficiency Syndrome. 565 autopsies in adult-swith the acquired imunodeficiency syndrome. Los Angeles, Calif, 1982–93.

Arch. Pathol. Lab. Med., 118 (1994), pp. 884-890

Medline

[18.]

J.L. Jones, O.R. Burwen, P.L. Fleming, J.W. Ward.

Tuberculosis among AIDS patients in the United States, 1993.

J. Acquir. Immune Defic. Syndr. Hum. Retrovirol, 1,2 (1996), pp. 293-297

Medline

[19.]

K.M. De Cock, B. Soro, I.M. Coullbaly, S.B. Lucas.

Tuberculosis and HIV infection in sub-Saharam Africa-JAMA, 268 (1992), pp. 1581-1587

[20.]

R.W. Shaper, K.D. Chirgwin, A.E. Glatt, M. DahDouh, S. Landesman, B. Suster.

HIV prevalence, immunosuppression and drug resistance in patients with Tuberculosis in a area endemic for AIDS.

AIDS, 5 (1991), pp. 399-405

Medline

[21.]

Centers for Disease Control.

Drug-resistant Tuberculosis among the homeless- Boston.

MMWR, 34 (1985), pp. 429

Medline

[22.]

M.L. Pearson, J.A. Jereb, T.R. Frieden, et al.

Nosocomial transmission of multidrug-resistant Mycobacterium Tuberculosis: a risk to patients and health care workers.

Ann. Intern. Med., 117 (1992), pp. 191-196

Medline

[23.]

M. Gobles, M.D. Iseman, L.A. Madsen.

Treatment of 171 patients with pulmonary Tuberculosis resistant to isoniazid and rifampin.

N. Engl. J. Med., 328 (1993), pp. 527-532

http://dx.doi.org/10.1056/NEJM199302253280802 | Medline

[24.]

M. Iseman, L.A. Madsen.

Drug resistant Tuberculosis.

Clln. Chest. Med., 10 (1989), pp. 341

[25.]

P.C. Hopewell.

Impact of human immunodeficiency infection on the epidemiology, clinical features, management and control of Tuberculosis.

Clin. Infect. Dis., 18 (1992), pp. 540-546

[26.]

L.N. Friedman, M.T. Williams, T.P. Singh, T.R. Friden.

Tuberculosis. AIDS. and death among substance abusers on welfare in New York City.

N. Engl. J. Med, 28 (1996), pp. 828-833

[27.]

B.R. Edlin, J.I. Tokars, N.H. Grieco, et al.

An outbreak of multidng-resistant Tuberculosis among hospilalized patients with the acquired imunodeficiency syndrome.

N. Engl. J. Med, 326 (1992), pp. 1514-1521

http://dx.doi.org/10.1056/NEJM199206043262302 | Medline

[28.]

Centers for Disease Control.

Nosocomial Transmission of multidrug-resistant Tuberculosis among HIV-infected persons-Florida and New York 1988-91.

MMWR, 40 (1991), pp. 585-591

Medline

[29.]

C. Beck-Sague, S.W. Dooley, M.D. Hutton, et al.

Hospital outbreak of multidrug resistant Mycobacterium Tuberculosis infections: factors in Transmission to staff and HIV-infected patients.

JAMA, 268 (1992), pp. 1280-1286

Medline

[30.]

S.E. Valway, S.B. Richard, J. Kovacovich, et al.

Outbreak of multidrug-resistant Tuberculosis in a New York State prison, 1991.

Am. J. Epidemiol., 140 (1994), pp. 113-122

Medline

[31.]

E. Nardell, Mcinnis, B. Thomas, S. Weidhaas.

Exogenous reinfection with Tuberculosis in a Shelter for the homeless.

N. Engl. J. Med., 315 (1986), pp. 1570-1575

http://dx.doi.org/10.1056/NEJM198612183152502 | Medline

[32.]

P.M. Small, R.W. Shafer, P.C. Hopewell, et al.

Exogenous reinfection with multidrug-resistant mycobacterium Tuberculosis in patients with advanced HIV infection.

N. Engl. J. Med., 328 (1993), pp. 1137-1344

http://dx.doi.org/10.1056/NEJM199304223281601 | Medline

[33.]

P. Pais.

HIV in India: Looking into the abyss.

Trop. Med. Int. Health, 1 (1996), pp. 295-304

Medline

[34.]

B.P. Vareldis, J. Grosset, L. Kantor, et al.

Laboratory evaluation of drug resistant Tuberculosis. WHO/TB/93.171.

Geneva e Tuberc. Lung. Dis, 75 (1994), pp. 1-7

[35.]

Centers for Disease Control.

Estimates of future global Tuberculosis morbidity and mortality.

JAMA, 271 (1994), pp. 739-741

Medline

[36.]

C. Whalen, C. Horsburgh, D. Hom, T.C. Lahar, M. Simberkoff, J. Ellner.

Accelerated course of human immunodeficiency virus infection after Tuberculosis.

Am. J. Respir. Crit. Care Med., 151 (1995), pp. 129-135

http://dx.doi.org/10.1164/ajrccm.151.1.7812542 | Medline

[37.]

A. Sehonanda, Y.J. Choi, S. Blum.

Changing patterns of autopsy findings among persons with acquired immunodefiiciency syndrome in an inner-city population. A 12-years retrospective study.

Arch. Pathol. Lab. Med., 120 (1996), pp. 459-464

Medline

[38.]

R.M. Selik, S.Y. Chu, J.W. Ward.

Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.

Ann Inter. Med., 123 (1995), pp. 933-936

[39.]

T.V. Perneger, P. Sudre, J.D. Lundgren, B. HirsChel.

Does the onset of Tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group.

BMJ, 311 (1995), pp. 1468-1471

Medline

[40.]

G.M. Cauthen, S.W. Dooley, I.M. Onorato, et al.

Transmission of Myeobacterium Tuberculosis from Tuberculosis patients with HJV infection or AIDS.

Am J. Epidemiol., 144 (1996), pp. 69-77

Medline

[41.]

J.A. Jereb, R.M. Klevens, T.D. Priveit, P.Y. Smith, J.T. Crawford, V.L. Sharp, B.J. Davis, W.R. Jarvis, S.W. Dooley.

Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium Tuberculosis.

Arch. Intern Med., 155 (1995), pp. 854-859

Medline

[42.]

P.N. Wenger, J. Otten, A. Breeden, D. Orfas, C.M. Beck-Sage, W.R. Jarvis.

Control of nosocomial transmission of muhidrug-resistant Mycobacterium Tuberculosis among heathcare workers and HIV-infected patients.

Lancet, 345 (1995), pp. 235-240

Medline

[43.]

R.L. Riley, E.A. Nardell.

Clearing the air: the Theory and application of ultra-violet air desinfection.

Am. Rev. Resp. Dis., 139 (1989), pp. 1286-1294

http://dx.doi.org/10.1164/ajrccm/139.5.1286 | Medline

[44.]

S.W. Doolex, K.G. Castro, M.D. Hutton, R.J. Mullan, J.A. Polder, D.E. Snider.

Guidelines for preventing the Transmission of Tuberculosis in health care settings, with special forms on HIVrelated issues.

MMWR, 39 (1990), pp. 1-29

Medline

[45.]

Iuatld, Tuberculosis Programme of The Word Health Organization (WHO).

Control of Tuberculosis transmission in health care senings.

Tuberc. Lung. Dis., 775 (1994), pp. 94-95

[46.]

DIRECÇÃO-GERAL DA SAÚDE. Transmissão nosocomial da Tuberculose. Circular nº7/DSDT, 7/9/94.

[47.]

Recomendações para a preveoção da Tuberculose nos Serviços de Saúde- Comissão de Tuberculose.

Arquívos S.P:P.R., 11 (1994), pp. 41-47

[48.]

Centers for Disease Control and Prevention.

1993 revised classification system from HIV infection and expanded surveillance definition for AIDS among adolescents and adults.

MMWR, 41 (1993), pp. 1-9

Medline

[49.]

M.L. Antunes.

Tuberculose em Portugal. Acta Médica Portuguesa, 8 (1995), pp. 559-565

[50.]

A.M. Dannenberg Jr..

Immunopathogenesis of pulmonary Tuberculosis.

Hosp. Pract, 28 (1993), pp. 33-40

[51.]

I.M. Orme, P.M. Collins.

Protection against Mycobacterium Tuberculosis infection by adoptive immunotherapy.

J. Exp. Med., 158 (1983), pp. 74-83

Medline

[52.]

L.M. Orme, P. Andersen, W.H. Bloom.

T-cell response to Mycobacterium Tuberculosis.

J. Infect. Dis., 167 (1993), pp. 1481-1497

Medline

[53.]

M. Forte, G. Maartens, M. Rahelu, et al.

Cyrolitic T-cell activity against mycobacterial antigens in HIV.

AIDS, 6 (1992), pp. 407-411

Medline

[54.]

B.S. Bender, B.L. Davidson, R. Kline, C. Brown, T.C. Quinn.

Role of mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infeccion and the acquired immunodeficiency syndrome.

Rev Infect. Dis., 10 (1988), pp. 1142-1154

Medline

[55.]

J.M. Beck, J. Shellito.

Effects of humman immunodeficiency virus on pulmonary host defenses.

Sem. Resp. Infect., 4 (1989), pp. 75

[56.]

P.F. Barnes, P.T. Davidson.

Tuberculosis in patients with HIV infection.

Med. Clin. North Am, 77 (1993), pp. 1369-1390

Medline

[57.]

A. Guelar, J.M. Gatel, J. Verdejo, et al.

A prospective study of the risk of Tuberculosis among HIV-infected patients.

AIDS, 7 (1993), pp. 1345-1349

Medline

[58.]

C.P. Theuer, P.C. Hopewell, D. Ellas, G.F. Schecter, G.S. Rutherford, R.E. Chaisson.

Human immunodeficiency vins infection in Tuberculosis patients J.

Infect. Dis., 162 (1990), pp. 8-12

[59.]

A. De Maria, A. Ferrazin, S. Ferrini, et al.

Selective increase in a subset of T-cell receptor T Lymphocytes in the peripheral blood of patients with human immunodeficiency virus type I infection.

J. Infect. Dis., 165 (1992), pp. 917-919

Medline

[60.]

M.M. Lederman, D. Georges, S.L. Zeichner, J.C. Alvine, Z. Toossi.

Mycobacterium Tuberculosis and its purified protein derivative activates expression of human immunodeficiency virus.

J. AIDS, 7 (1994), pp. 727-733

[61.]

J.M. Fitzgerald, S. Grzybowski, E.A. Allen.

The impact of human immunodeficiency virus infection on Tuberculosis and its control.

Chest, 100 (1991), pp. 191

Medline

[62.]

Y. Zhang, K. Nakata, W.N. Rom.

Mycobacterium Tuberculosis enhances HIV replication by transcriptional activation of the long terminal repeat.

J. Clin. Invest, (1995), pp. 95

[63.]

R.S. Wamis, M. Vjecha, Amir-Tahmasseb, et al.

Influence of Tuberculosis on human immunodeficiency virus (HIV+ 1): enhanced cytokine expression and elevated β2- microglobulin in HIV-1 associated Tuberculosis.

J. Infect. Dis., 167 (1993), pp. 43-48

Medline

[64.]

J. Chrétien.

Tuberculosis et VIH- Un couple maudit.

Bull. Int. Union Tuberc. Lung. Dis., 65 (1990), pp. 27-30

Medline

[65.]

P.F. Barnes, C. Silva, M. Otaya.

Testing for human immunodeficiency virus infection in patients with Tuberculosis.

Am J. Resp. Care Med., 153 (1996), pp. 1448-1450

[66.]

T.B. Kim, et al.

Acid fast bacillus in sputum smears of patients with pulmonary Tuberculosis.

Am. Rev Respir. Dis., 129 (1984), pp. 264-268

Medline

[67.]

P.F. Barnes, T.O. Verdegen, L.A. Vachon, J.M. LeeDom, G.D. Overtuf.

Chest roentgenogram in pulmonary Tuberculosis.

Chest, 94 (1988), pp. 316-320

Medline

[68.]

R.L. Smith, K. Yew, K.A. Beakowitz, C.P. Aranda.

Factors affecting the yield of acid-fast sputum smears in patients with HIV and Tuberculosis.

Chest, 106 (1994), pp. 684-686

Medline

[69.]

E. Louie, L.B. Rice, I.U. Holzman.

Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome.

Chest, 90 (1986), pp. 542

Medline

[70.]

D.J. Kennedy, W.P. Lewis, P.F. Barnes.

Yield of broneoscopy for the diagnosis of Tuberculosis in patients with human immunodencicncy virus infection.

Chest, 102 (1992), pp. 143-146

Medline

[71.]

F. Kramer, T. Modilevsky, A.R. Waliany, et al.

Delayed diagnosis of Tubcrculosis in patients with human immunodeficiency virus infection.

Am J. Med., 89 (1990), pp. 451-456

Medline

[72.]

I.K. Taylor, R.J. Coker, J. Clarke, et al.

Pulmonary complications of HIV disease: 10 year retrospective evaluation on yields from bronchoalveolar Lavage, 1983-93.

Thorax, 50 (1995), pp. 1240-1245

Medline

[73.]

C.L. Daley, F. Mugusi, L.L. Chen.

Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronehoalveolar lavage.

Am J. Resp. Crit. Care Med, 154 (1996), pp. 105-110

http://dx.doi.org/10.1164/ajrccm.154.1.8680664 | Medline

[74.]

M. Di Lonardo, N.C. Isola, M. Ambroggi, A. Rybko, S. Poggi.

Mycobacteria in HIV-infected patients in Buenos Aires.

Tubere. Lung, Dis, 76 (1995), pp. 185-189

[75.]

J.W. Buehler, J.W. Ward.

A new case definition for AIDS surveillance.

Am Intern. Med., 118 (1993), pp. 390-392

[76.]

G. Middlebrook, Z. Regglardo, W.D. Tigert.

Automatable radiometric detection of growth of Mycobacterium Tuberculosis in selective media.

Am. Rev Respir. Dis., 115 (1977), pp. 1066-1069

http://dx.doi.org/10.1164/arrd.1977.115.6.1066 | Medline

[77.]

P.O. Ellner, T.E. Kiehn, R. Cammarata, M. Hosmer.

Rapid detection of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods.

J. Clin. Microbiol., 26 (1988), pp. 1349-1352

Medline

[78.]

K.D. Eisenach, M.D. Sifford, M.D. Care, J.H. Bates, J.T. Crawford.

Detection of Mycobacterium Tuberculosis in sputum samples using a polymerase chain reaction.

Am. Rev Resp. Dis., 144 (1991), pp. 1160-1163

http://dx.doi.org/10.1164/ajrccm/144.5.1160 | Medline

[79.]

P. Scarpellini, S. Racca, P. Cinque, et al.

Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with Tuberculosis meningitis.

AmS, 9 (1995), pp. 895-900

http://dx.doi.org/10.5114/aoms.2013.38684 | Medline

[80.]

J.D.A. Van Embden, M.D. Care, J.T. Crawford, et al.

Strain identification of Mycobacterium Tuberculosis by DNA fingerprinting: recommendation for a standardized methodology.

J. Clin. Microbiol., 31 (1993), pp. 406-409

Medline

[81.]

G.H. Bothamley.

Serological diagnosis of Tuberculosis.

Eur. Respir. J. Suppl, 20 (1995), pp. 676s-688s

Medline

[82.]

J. Krysl, M. Korzeniewska-Kosela, N. Muller, J.M. Fitzgerald.

Radiologic features of pulmonay Tuberculosis: na assessment of 188 cases.

Can. Assoc. Radiol. J., 45 (1994), pp. 101-107

Medline

[83.]

P.F. Barnes, T.O. Verdegen, L.A. Vachon, J.M. Lee-Dom, G.O. Overdruf.

Chest roentgenogram in pulmonary Tuberculosis New data on na old test.

Chest, 94 (1988), pp. 316-320

Medline

[84.]

M. Holden, M.R. Dubin, P.H. Diamond.

Frequency of negative intermediate-strength tuberculosis sensivity in patients with active tuberculosis.

N Engl. J. Med., 285 (1971), pp. 1506-1509

http://dx.doi.org/10.1056/NEJM197112302852704 | Medline

[85.]

A.M. Elliott, N.L. Luo, G. Tembo, et al.

Impact of HIV on Tuberculosis in Zambia: a cross sectional study.

Sr. Med. J., 301 (1990), pp. 412-415

[86.]

R.E. Chaisson, G.F. Schecter, G.W. Theuer, et al.

Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy and survival.

Am. Rev Resp. Dis., 136 (1987), pp. 570-574

http://dx.doi.org/10.1164/ajrccm/136.3.570 | Medline

[87.]

R.D. Moore, R.E. Chaisson.

Natural History of opportunistic disease in an HIV-infected urban clinical cohort.

Ann. Intern. Med., 124 (1996), pp. 633-642

Medline

[88.]

S.B. Lucas, A. Hounnou, C.S. Peacock, et al.

The mortality and pathology of HIV disease in a West African city.

AIDS, 7 (1993), pp. 1569-1579

Medline

[89.]

M.P. Johnson, J.S. Coberly, H.C. Clermont, et al.

Tuberculin skin reactivity among adults infected with human immunodeficiency virus.

J. Infect. Dis., 166 (1992), pp. 194-198

Medline

[90.]

D.L. Hanson, S.Y. Chu, K.M. Farizo, J.W. Ward.

Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome- defining and other human immunodeficiency vimsor related illnesses The Adult and Adolescent Spectrum of HIV Disease Project Group.

Arch. Intern. Med., 155 (1995), pp. 1537-1542

Medline

[91.]

C. Bem, P.S. Patil, N. Wo.

The increased burden of Tuberculosis lymphadenitis in central Africa: Limph node biopsies in Lusaka, Zambia, 1981 and 1990.

Trop. Doct., 26 (1996), pp. 58-61

Article | Medline

[92.]

M. Whiteman, L. Espinoza, M.J. Post, M.D. Bell, S. Fakin.

Central Nervous System TuberculosisClinical and radiographic findings.

Im. J. Neuroradiol., 16 (1995), pp. 1319-1327

[93.]

S.J. Antony, D.W. Haas.

Tuberculous pericarditis in an HIV infected patient.

Scand. J. Infect. Dis., 27 (1995), pp. 411-413

Medline

[94.]

M.A. Karawi, A.E. Mohamed, M.I. Yasawy, et al.

Protean manifestations of gastrointestinal tuberculosis - report on 130 patients.

J Clin. Gastroenterol., 20 (1995), pp. 225-232

Medline

[95.]

S.D. Greenberg, D. Frager, B. Suster, et al.

Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance).

Radology, 193 (1994), pp. 115-119

[96.]

B.E. Jones, et al.

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency infection.

Am. Rev Resp. Dis., 148 (1993), pp. 1292-1297

http://dx.doi.org/10.1164/ajrccm/148.5.1292 | Medline

[97.]

E.Y. Kang, C.A. Staples, G. Mcguiness, S.L. Primack, N.L. Muller.

Detection and differencial diagnosis of pulmonary infections and tumors in patients with ALDS: value of chest radiography versus CT.

Am. J. Roemgenol, 166 (1996), pp. 15-19

[98.]

M. Hawken, P. Nunn, S. Gathma, et al.

Incresead recurrence of Tuberculosis in HI V-1 infected patients in Kenya.

Lancet, 342 (1993), pp. 332-337

Medline

[99.]

J.H. Perriëns, E. Michael, B. Yadiul, et al.

Pulmonary Tuberculosis in HIV-1 infected patients in Zaire - a controlled trial of treatments for either 6 or 12 months.

N. Engl. J. Med., 332 (1995), pp. 779-784

http://dx.doi.org/10.1056/NEJM199503233321204 | Medline

[100.]

K.G. Castro.

Tuberculosis as an opportunistic disease in persons infected with immunodeficiency virus.

Clin. Infect. Dis, 21 (1995), pp. 566-571

[101.]

P.M. Small, G.F. Schcter, P.C. Goodman, et al.

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.

N. Engl. J. Med., 324 (1991), pp. 289-294

http://dx.doi.org/10.1056/NEJM199101313240503 | Medline

[102.]

P. Nunn, D. Kubuga, S. Gathur, et al.

Cutaneous hypersensitivity reaction due to thiacetazones in HIV-1 seropositive patients treated for tuberculosis.

Lancet, 37 (1991), pp. 27-630

[103.]

S.E. Weis, P.C. Slocum, F.X. Blais.

The effects of directly observerd terapy on the rates of drug resistance and relapse in tuberculosis.

N. Engl. J. Med., 330 (1994), pp. 1179-1184

http://dx.doi.org/10.1056/NEJM199404283301702 | Medline

[104.]

M.O. Iseman, D.L. Cohn, J.A. Sbarbaro.

Directly observed treatment of tuberculosis We can't afford not to try it.

N. Engl. J. Med., 328 (1993), pp. 576-578

http://dx.doi.org/10.1056/NEJM199302253280811 | Medline

[105.]

C. Whalen, A. Okwera, J. Johnson, et al.

Predictors of survival in human immunodeficiency virus infected patients with pulmonary Tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.

Am J. Respir. Crit. Care Med, 156 (1996), pp. 1977-1981

[106.]

N. Salomon, D.C. Perlman, P. Friedman, et al.

Predictors and outcome of multidrug-resistant Tuberculosis.

Clin. Infect. Dis., 21 (1995), pp. 1245-1252

Medline

[107.]

G.S. Turett, E.E. Telzak, L.V. Torian, et al.

Improved outcomes for patients with multidrugresistant Tuberculosis.

Clin. Infect Dis., 25 (1995), pp. 1238-1244

[108.]

K. Neville, A. Bromberg, R. Bromberg, S. Bonk, B.A. Hanna, W.N. Rom.

The third epidemicmultidrug-resistant Tuberculosis.

Chest, 105 (1994), pp. 45-48

Medline

[109.]

W.W. Yew, C.H. Chau.

Drug resistant Tuberculosis in the 1990s.

Eur. Resp. J., 8 (1995), pp. 1184-1192

[110.]

C.A. Peloquin, A.A. Macphee, S.E. Berning.

Malabsorption of antimycobacterial medications.

N. Engl. J. Med., 329 (1993), pp. 1122-1123

http://dx.doi.org/10.1056/NEJM199310073291513 | Medline

[111.]

G.A. Colditz, T.F. Brewer, C.S. Berkey, et al.

Efficacy of BCG vaccine in the prevention of Tuberculosis.

JAMA, 271 (1994), pp. 698-702

Medline

[112.]

P.E.M. Fine.

Variation in protection by BCG: Implications of and for heterologous immunity.

Lancet, 346 (1995), pp. 1339-1345

Medline

[113.]

A.C. Weltman, O.N. Rose.

The safety of bacille Calmette-Guérin Vaccination in HIV infection and AIDS.

AIDS, 7 (1993), pp. 149-157

Medline

[114.]

Who/Iuatld.

Tuberculosis and AJDS. Statement on AIDS and Tuberculosis.

Bull. Int. Union. Tuberc. Lung. Dis, 64 (1989), pp. 8-11

Medline

[115.]

M.K. Felten, M. Leichsenring.

Use of BGG in high prevalence areas of HIV.

Trop. Med. Parasitol., 46 (1995), pp. 69-71

Medline

[116.]

Centers for Disease Control.

National Action plan to combat multidrug resistant tuberculosis: Meeting the challenge of multidrug resistant tuberculosis - summary of a conference- management of persons exposed to multidrug-resistant tuberculosis.

MMWR, 41 (1992), pp. 1-71

Medline

*

Texto em parte apresentado no “XII Congresso de Pneumologia” (Porto, 10 a 13 de Novembro de 1996)

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter